Category: Latest News
-
Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test
Shares of Castle Biosciences Inc (NASDAQ:CSTL) rose 7.8% after the company announced that its DecisionDx-Melanoma test has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The diagnostic test, which analyzes gene expression, is designed to offer personalized insights for patients with stage I-III cutaneous melanoma. It aids clinicians in tailoring post-diagnosis…
-
Humacyte shares climb 6% after first Symvess sale to U.S. military hospital
Shares of Humacyte Inc (NASDAQ:HUMA) rose 6.1% after the company announced its first commercial sale of Symvess to a U.S. Military Treatment Facility. The sale was made to a major military medical center located on a large U.S. base, which provides care to around 200,000 active-duty personnel, veterans, and their families. The milestone follows Symvess’s…
-
Pony.ai stock climbs 5% as Gen-7 Robotaxi begins testing in Beijing
Pony.ai Inc (NASDAQ:PONY) shares rose 5.2% after the autonomous driving company announced it has begun road testing its seventh-generation BAIC Robotaxi in Beijing. The new Gen-7 fleet is now operating within Beijing’s High-Level Autonomous Driving Demonstration Zone, which spans 225 square kilometers. This milestone marks the latest phase in Pony.ai’s expansion, as the company is…
-
IonQ shares edge higher after forming quantum tech partnership with Emergence Quantum
IonQ (NYSE:IONQ) saw its stock climb 1.3% following news of a strategic partnership with Australia-based research firm Emergence Quantum aimed at advancing ion trap quantum computing technologies. The collaboration will focus on co-developing cutting-edge materials and electronics, particularly in designing and simulating application-specific integrated circuits (ASICs) for qubit control. Efforts will also be made to…
-
OFA Group shares jump after unveiling $100 million digital asset treasury
OFA Group (NASDAQ:OFAL) saw its stock surge 26.6% following the announcement of a $100 million digital asset treasury initiative, alongside the appointment of Bitwise Asset Management to oversee its cryptocurrency strategy. Fresh off celebrating its IPO with a Nasdaq closing bell event, the architecture and technology firm revealed that this digital asset treasury is part…
-
Avidity Biosciences shares climb after FDA grants Breakthrough Therapy designation
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) rose 4% Wednesday following the announcement that its drug candidate, delpacibart zotadirsen (del-zota), has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration. The designation applies to del-zota for treating Duchenne muscular dystrophy (DMD) in patients with mutations eligible for exon 44 skipping. This FDA status…
-
U.S. Stocks Gain on U.S.-Japan Trade Deal Hopes; Tesla, Alphabet Earnings in Focus
U.S. equity markets climbed on Wednesday, buoyed by optimism surrounding a new trade agreement between the United States and Japan. Investors also turned their attention to upcoming earnings reports from tech heavyweights Tesla and Alphabet. As of 09:35 ET, the Dow Jones Industrial Average was up 245 points (0.6%), the S&P 500 gained 23 points…
-
Infosys Q2 results meet earnings forecasts while revenue exceeds expectations
Infosys Limited (NYSE:INFY), the global leader in digital services and consulting, reported second-quarter earnings in line with analyst estimates, while revenue outperformed projections, leading to a modest 0.2% increase in its share price after the announcement. The company posted earnings per share of $0.19 for the quarter, matching the consensus forecast. Revenue reached $4.94 billion,…
-
First Busey shares climb after Q2 earnings surpass forecasts
Shares of First Busey Corporation (NASDAQ:BUSE) rose 2.9% following the regional bank’s announcement of second-quarter earnings that beat analyst projections, largely driven by strong revenue growth after acquiring CrossFirst Bankshares (NASDAQ:CFB). The bank reported adjusted earnings of $0.63 per share, exceeding the $0.60 consensus estimate. Revenue reached $198.05 million, topping the forecasted $193.73 million and…
-
Amphenol shares climb 6% on robust IT datacom-driven Q2 results
Amphenol Corporation (NYSE:APH) saw its shares rise 6% after reporting second-quarter earnings that far surpassed analyst predictions, fueled by outstanding growth in its IT datacom segment. The company posted adjusted earnings per share of $0.81, outperforming the estimated $0.66 by 23%. Revenue surged to $5.7 billion, marking a 57% year-over-year increase and well exceeding the…